Navigation Links
Dramatic increase in 'Tommy John' surgery in young patients cause for concern
Date:7/11/2008

ORLANDO, Florida Eighty-three percent of athletes who had "Tommy John" elbow reconstruction surgery were able to return to the same or better level of play, according to a study released today at the 2008 American Orthopaedic Society for Sports Medicine Annual Meeting at JW Marriott Orlando Grande Lakes. While reassuring to athletes, the study authors find the trend of more and more young athletes requiring the surgery, alarming.

"Before 1997 this surgery was performed on only 12 of 97 patients who were 18 or younger (12 percent)," said co-author E. Lyle Cain, MD, fellowship director for the American Sports Medicine Institute, Andrews Sports Medicine and Orthopaedic Center in Birmingham, Alabama. "In 2005 alone, 62 of the 188 operations performed, were on high school athletes, a third of the surgical group. The reality is that this surgery is successful and that's good. But a disturbing trend of younger kids needing the surgery is troubling. This should be a wake-up call to parents and coaches that specialization in baseball where kids don't get adequate time off is very dangerous."

"Tommy John" surgery is a procedure where a damaged elbow ligament (Ulnar Collateral Ligament or UCL) is replaced with a tendon from elsewhere in the body. The surgery is named for Hall of Fame pitcher Tommy John, who was the first person to have the surgery in 1974. John returned to the major leagues and went on to win 164 games after the surgery. Prior to this historic surgery, a UCL injury was a career-ending injury.

In the study, 743 patients who had the Tommy John surgery were contacted for follow-up evaluations and completed a questionnaire about their recovery. The majority of the patients were baseball players (94.5 percent), the remaining 5.5 percent were involved in track, football or other sports. The study found that 622 patients (83 percent) returned to the previous level of competition or higher. Of the major league players, 75.5 percent returned to the same level of play. For minor league players 56 percent returned to the same level or higher. The average time from surgery to full competition was 11.6 months after reconstruction, according to study results. Additionally about 10 percent of the patients had complications, mostly minor.

"The increase in the number of UCL reconstructions being done now can be attributed to many things: improved diagnostic techniques, heightened awareness, increased chance of positive outcome with current surgical techniques, but most importantly, the overuse of young throwing arms," said Dr. Cain. "In the past 10 years, year-round baseball leagues have proliferated. So the best young pitchers are throwing many more pitches and learning to throw more difficult pitches. It's great that the surgery is successful, but prevention of the injury should be the goal. Kids should be urged to rest and be careful about saving their arms, rather than leading to long-term problems at a young age."


'/>"/>

Contact: Lisa Weisenberger
lisa@aossm.org
847-292-4900
American Orthopaedic Society for Sports Medicine
Source:Eurekalert

Related medicine news :

1. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
2. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction
3. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
4. Batters may achieve dramatic increases in home runs through steroids
5. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
6. Early intervention dramatically improves outcomes for new dialysis patients
7. UCLA Research Shows Dramatic Savings for Medicaid When Head Start Parents Learn to Care for Kids Illnesses
8. Dramatic Growth Projected in Visits by Elderly Patients to Emergency Departments Underscores Urgency of Medicare Physician Payment Fix
9. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
10. Technology can Dramatically Reduce Billions of Dollars in Medicaid, Medicare Fraud
11. New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... services, is proud to announce the guest speaker lineup* for its second annual ... Alliance of Healthcare Purchaser Coalitions; Dr. Keith Fernandez of Privia Health; and Lisa ...
(Date:6/28/2017)... PA (PRWEB) , ... June 28, 2017 , ... ... host a one-day corporate governance program for mid-market executives as a kick-off to ... be held Sunday, Sept. 24, 2017 on the University of Pennsylvania campus, followed ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... management and financial planning assistance to clients in southern Montana, is announcing a ... by Zoo Montana. , The outreach programs offered by Zoo Montana provide students ...
(Date:6/27/2017)... ... June 27, 2017 , ... Excel Medical, the leader ... the position of Executive Vice President, Sales and Marketing. Finnegan is a widely ... medical device sales leadership. He has received industry recognition for innovations and new ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... MAITLAND, Fla. , June 8, 2017  Less ... ransomware attack that hit more than 200,000 companies, including hospital ... is being heralded as one of the largest online ... technology in the healthcare market, it is imperative that ... can protect their data from this — and many ...
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: